Drug safety. Heart attack risk overshadows a popular diabetes therapy.
作者信息
Couzin Jennifer
出版信息
Science. 2007 Jun 15;316(5831):1550-1. doi: 10.1126/science.316.5831.1550.
Abstract
摘要
相似文献
1
Drug safety. Heart attack risk overshadows a popular diabetes therapy.药物安全性。心脏病发作风险使一种常用的糖尿病治疗方法黯然失色。
Science. 2007 Jun 15;316(5831):1550-1. doi: 10.1126/science.316.5831.1550.
2
The painful truth.痛苦的真相。
Eur Heart J. 2010 May;31(10):1284-5. doi: 10.1093/eurheartj/ehq126. Epub 2010 Apr 23.
3
Weighing up the evidence.权衡证据。
Nature. 2007 May 31;447(7144):512-3. doi: 10.1038/447512a.
4
The rosiglitazone meta-analysis.罗格列酮荟萃分析。
Rev Cardiovasc Med. 2007 Spring;8(2):123-6.
5
Rosiglitazone, marketing, and medical science.罗格列酮、市场营销与医学科学。
BMJ. 2010 Apr 7;340:c1848. doi: 10.1136/bmj.c1848.
6
The Avandia debate.文迪雅之争
Diabetes Care. 2007 Sep;30(9):2401-8. doi: 10.2337/dc07-zb09.
7
Heart-stopping news. The diabetes drug Avandia is under fire: what you should know. Interview by Avery Comarow.令人震惊的消息。糖尿病药物文迪雅正面临抨击：你应该了解的情况。艾弗里·科马罗采访报道
US News World Rep. 2007 Jun 4;142(20):64.
8
Diabetes drug safety update: Avandia and your heart.糖尿病药物安全性更新：文迪雅与您的心脏
Johns Hopkins Med Lett Health After 50. 2010 Jun;22(4):1-2, 7.
9
The rosigliazone meta-analysis: lessons for the future.罗格列酮荟萃分析：对未来的启示。
Diabetes Care. 2008 Mar;31(3):e10. doi: 10.2337/dc07-2147.
10
Avandia in perspective.文迪雅的视角。
US News World Rep. 2007 Oct 1;143(11):71.
引用本文的文献
1
Therapeutic interventions and oxidative stress in diabetes.糖尿病中的治疗干预与氧化应激
Front Biosci (Landmark Ed). 2009 Jan 1;14(1):192-209. doi: 10.2741/3240.
Zotero 插件